Thus, markers CA15-3, CA27.29, and MCA can indirectly reflect changes occurring at the systemic level in breast cancer with HER2-positive expression, in our case, the luminal B(+) type of breast cancer. This evidence concerns the gene ERBB2 and breast cancer.